Marvel's Box Office Correction: What 2025's Numbers Actually Said, And What Changed

2025 was the year the conversation about Marvel Studios changed from how much will it make to will it make enough. Three films released, three different outcomes, and one uncomfortable statistic sitting underneath all of them: not a single Marvel title appeared in the year's global top ten. That had not been true in over a decade.

The discourse around this has been unhelpfully binary - either Marvel is finished or the numbers are fine and everyone is overreacting. Neither is right. What actually happened is more specific, and understanding it explains almost every scheduling decision the studio has made since.

The Numbers, Without Spin

Total worldwide for the year: roughly $1.32 billion across three films. For context, Endgame alone did $2.799 billion. That comparison is unfair and everybody keeps making it anyway, which is part of the problem - it sets a benchmark that was never repeatable and then treats every subsequent result as a decline from it.

Three Films, Three Different Problems

Brave New World: the quality problem

Brave New World made $413.6 million against a $180 million budget - a number that, before marketing costs, looks survivable. It reviewed at 47%, and that is the number that actually mattered. Sam Wilson taking the shield was a story Marvel had spent an entire Disney+ series setting up, and the film did not deliver a version of it that anyone argued about afterwards. It made money and lost the conversation.

Thunderbolts*: the awareness problem

Thunderbolts* is the genuinely painful one. It reviewed at 88%, the best of Phase 5, and it lost money - $382.4 million worldwide against a $180 million budget plus a global marketing spend. Nothing was wrong with the film. What was wrong was that a team of characters most of the general audience could not name, marketed under a title with an asterisk in it, required an audience to take a leap it had no reason to take.

First Steps: the ceiling problem

The Fantastic Four: First Steps was the year's bright spot at $519.1 million and 87%, and it still did not crack the global top ten. Reed Richards and Sue Storm finally got a version of their story that critics and audiences agreed worked - and the ceiling on that success turned out to be about half a billion. That is the most instructive number of the three, because it tells you what a good, well-received, non-Avengers Marvel film is currently worth.

The lesson of 2025 is not that Marvel makes bad films. Thunderbolts* was excellent and lost money. The lesson is that quality is now necessary and no longer sufficient.

What Actually Changed

1. The automatic-attendance audience shrank. There is still a large group who see every Marvel film; it is smaller than it was in 2018 and it no longer carries a film on its own.
2. Budgets did not come down to meet the new reality. Two $180M films and one $200M film in a year where $519.1M is the ceiling is a structural mismatch.
3. Streaming reset the urgency. A film that will be on Disney+ within months competes with itself.
4. Character equity now has to be earned per-film. Thunderbolts* proved that good reviews cannot substitute for an audience knowing who these people are.
5. The event tier and the regular tier separated. Avengers films are still events; everything else has to sell itself individually.

How Marvel Has Responded

The response has been mostly about scheduling and concentration, and it is visible across the slate.

• Avengers: Doomsday moved from 1 May 2026 to 18 December 2026, into the holiday corridor where multipliers are strongest.
• Avengers: Secret Wars moved with it, from 7 May 2027 to 17 December 2027.
• 2026 theatrical output is two films, not three or four.
• Blade sits with no date and no director, reportedly shelved but not formally cancelled.
• Disney+ output has narrowed toward fewer, better-reviewed series rather than volume.

We covered the Doomsday move in detail in our piece on the date change, and the Blade situation in our status report. Both are symptoms of the same recalculation: fewer bets, placed more carefully.

Which Makes Friday Enormous

Spider-Man: Brand New Day opens on 31 July 2026, tracking for a $180M+ domestic debut that would be the year's biggest. Spider-Man has always been the least fragile property in this portfolio - it survived 2025's correction by not being in it - and a strong result would materially change the narrative going into December.

It would not fix the structural issue. A $180M opening for Spider-Man tells you Spider-Man works, which nobody doubted. The real test of whether the correction is over comes with films that do not have a decade of goodwill and three separate live-action franchises behind them. But it would buy the studio a much better five months of headlines before Doomsday arrives.

What To Watch Next

Three indicators over the next eighteen months. First, Brand New Day's multiplier rather than its opening - legs tell you about audience satisfaction in a way a debut never does. Second, whether Doomsday's December positioning produces the holiday-corridor performance it was moved for. Third, whether budgets on the 2028-29 projects come in under the $180-200M band that has been squeezing margins.

That third one is the real tell, and it will be the quietest. Nobody announces a budget reduction. You find out eighteen months later, in a trade report, buried in a paragraph about something else. For where the slate currently stands, see our full roadmap.